Context: Anecdotal reports suggest that increasing numbers of children in the UK are presenting with clinical manifestations of vitamin D deficiency (VDD). However, the epidemiology of symptomatic VDD is largely undetermined; existing studies are limited to local case series, and national incidence estimates of disease burden are lacking.
of UK and Irish pediatricians in 2009) receive monthly reporting cards (5) . Response rates are high (93.3% in 2012) (6) . Surveillance of hypocalcaemic seizures secondary to VDD ran from September 2011 to September 2013. Pediatricians who reported cases were sent a data-collection form requesting case details.
Case definition
Pediatricians were asked to report children aged 0 -15 years with a suspected seizure in the presence of both:
1. Serum corrected calcium Ͻ 2.0 mmol/L 2. Serum 25-hydroxyvitamin D (25-OH-D) Ͻ 50 nmol/L Children with a previous hypocalcaemic seizure due to VDD were excluded. The 25-OH-D cut-off of Ͻ 50 nmol/L defines insufficiency in UK and international guidance (1, 7) .
Case details were assessed for the following exclusion criteria:
1. An alternative cause of seizures. 2. Pathology that can cause secondary VDD [eg, chronic renal or liver disease, gastrointestinal (GI) disease with malabsorption, inherited disorders of vitamin D metabolism].
Cases meeting the above criteria were defined as "confirmed" cases.
In some reports pretreatment blood samples were insufficient for 25-OH-D measurement, although the working diagnosis was a hypocalcaemic seizure secondary to VDD. These were defined as "probable" cases if they otherwise met the case definition, and Ն 1 additional feature suggestive of rickets was present:
1. High serum alkaline phosphatase (ALP) or parathyroid hormone (PTH), according to the local reference range.
Radiological signs of rickets (reported by clinician).

Data collection form
Minimal patient identifiers (NHS number, hospital number, date of birth, sex, district level postcode) were collected to identify duplicate reports. Ethnicity was recorded using UK Census 2001 categories (8) . Details regarding clinical presentation, comorbidities, investigations, and clinical management were requested.
Denominator data
Mid-2012 population estimates from the UK Office for National Statistics and Irish Central Statistics Office were used for incidence calculation (9, 10) . Population data stratified by ethnicity was only available for children age 0 -14 years in England, Wales, and ROI, using 2011 estimates (9, 10) .
Statistical analysis
Data are summarized using means and standard deviations if approximately normally distributed, or medians and interquartile ranges if non-normal. Confidence intervals around incidence estimates were calculated using the exact Poisson method. Differences in biochemistry by age were examined using independent t-tests for normally distributed data and Wilcoxon ranksum tests for non-normal data. Analyses were performed using StataSE 13.1.
Ethical approval
Ethnical approval was obtained from the London Central Research Ethics Committee (Ref:11/LO/0838). Approval for collection of patient identifiers without consent was obtained from the National Information Governance Board (ECC/ BPSU/6-02(FT7)/2011).
Results
Of 137 notifications in total, there were 81 confirmed and 10 probable cases. Eighteen were duplicate notifications, and 18 did not meet the case criteria (Supplemental Figure  1 ). Case status could not be ascertained for 10 notifications (7%), because the clinicians could not recall patient details (n ϭ 5) or did not respond, despite several reminders (n ϭ 5). The 91 confirmed and probable cases were included for analysis.
Most cases were male (82%), and from high-risk ethnic groups ( Table 1 ). The cases fell into two age groups: 95% were young children aged 0 -2 years, and 5% were adolescents aged 11-15 years. There was a seasonal pattern in presentation (Supplemental Figure 2) .
The estimated annual incidence of hypocalcaemic seizures secondary to VDD was 3.49 per million children age 0 -15 years (95% CI: 2.81-4.26). Incidence was significantly greater in males compared to females, in infants compared to older children, and in children from South Asian or Black compared to White ethnic backgrounds ( Table 2) .
Sixty one percent had multiple seizures. In most cases seizure duration was Ͻ 5 min (69%), with seizures lasting Ն 10 min in 19%. 80% of children did not have other clinical features of VDD, while 15% exhibited features of rickets. Serum biochemistry is shown in Table 1 , and the relationship between biochemistry and age in Supplemental Figure 3 and Supplemental Table 1 . Where available, 25-OH-D levels were Ͻ 25 nmol/L in 86% of children and 71% of mothers. Radiographs were performed in 30 cases, with 23 exhibiting features of rickets (77%). Electrocardiograms were performed in 40 cases, with a prolonged QT interval reported in 16 (40%).
Ninety eight percent of cases were admitted to hospital, for a median duration of 3 days (IQR: 2-5). Fifty one percent were given acute treatment to terminate a seizure or prevent recurrence (Table 1) . Seventy eight children (87%) received colecalciferol or ergocalciferol, of whom 9 were given single high-dose stoss therapy [intramuscular (IM) in 7 cases and oral in 2]. Twelve children (13%) received alfacalcidol, while 3 (3%) received vitamin D replacement only in the form of Abidec or Dalivit multivitamin preparations. No children died, and one had sequelae at discharge (a burn from extravasation of IV calcium gluconate).
Discussion
This is the first study in the UK to report national incidence estimates for any clinical manifestation of VDD. Most
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Basatemur and Sutcliffe Hypocalcemic Seizures Due to Vitamin D Deficiency J Clin Endocrinol Metab, January 2015, 100(1):E91-E95 previous studies of symptomatic VDD are single or multicenter case series (2) (3) (4) . The exception is a regional prospective study in children aged up to 5 years, conducted in the West Midlands between 2000 and 2001, which identified 24 cases of symptomatic VDD equating to an incidence of 7.5 per 100 000 (11) . Six cases presented with hypocalcaemic convulsions. However, the results are not generalizable to the UK as a whole, due to regional differences in ethnic demography; the West Midlands has a higher South Asian population, particularly Pakistani, than the UK average (9) . National incidence estimates for symptomatic VDD are available for Denmark (2.9 per 100 000 children age 0 -14 years) and Canada (2.9 per 100 000 children age 0 -18 years) (12, 13) . Previous reports suggest that hypocalcaemic seizures represent 12-25% of cases of symptomatic VDD presenting to secondary care, depending on the age of children included (2, 4, 11, 13) . We chose to limit our study to hypocalcaemic seizures, rather than investigate symptomatic VDD more broadly, for two reasons. Firstly, we anticipated that musculoskeletal manifestations of VDD might present to healthcare professionals other than pediatricians, such as general practitioners and orthopedic surgeons. Secondly, we anticipated that the incidence of rickets as a whole could exceed the recommended capacity for BPSU studies (300 cases per year).
Our results are consistent with previous reports that South Asian and Black ethnic groups are at the highest risk of symptomatic VDD (2) (3) (4) 11) . Hypocalcaemic symptoms present in two distinct periods, early childhood (most cases) and adolescence (2, 4) , possibly because of higher metabolic demand for calcium during these periods of rapid bone growth (1, 4) . Eleven children were from White backgrounds: two adolescents with autistic spectrum disorders and restricted diets, one 2-year-old with multiple allergies and a restricted diet, and eight aged between 0 and 2 years without comorbidities.
We observed an unexpected male predominance, which has been reported in two previous case series, a Turkish study of 93 infants aged 1-24 months with hypocalcaemic seizures due to suspected rickets (14) , and an American study of 78 term neonates (age Ͻ 31 days) with transient hypocalcaemia (15) . In our study, the male predominance was present in both neonates (79%) and children aged Ն 1 month (85%). Males aged 0 -36 months are reported to have higher bone mineral content than females (16) , and we hypothesize whether gender-specific differences in metabolic calcium demand during periods of rapid growth may predispose males to hypocalcaemia in the presence of VDD.
Phosphate levels were not depressed as expected in VDD rickets, a finding previously reported in children with hypocalcaemic presentations of VDD (4). The authors have suggested that this could be due to presentation in the early stage of VDD, before a secondary hyperparathyroid response has developed, or due to PTH resistance in the later stages of deficiency (1, 4) . We observed a difference in the pattern of serum biochemistry by age, with neonates exhibiting lower ALP, PTH, and higher phosphate levels compared to older children. Previous studies of neonatal hypocalcaemia have reported low vitamin D levels in combination with low/normal PTH levels and hyperphosphataemia (15) . The authors have proposed that various factors may play a synergistic role in the development of hypocalcaemia in neonates, including late maturation of the parathyroid axis, hypomagnesaemia, and VDD (15) .
The main strength of the study is the use of an established active surveillance system, with national coverage and consistently high response rates. However, there are several limitations. We were unable to ascertain the case status for a minority of reports (7%), similar to previous BPSU studies (5-10%) (17, 18) . A degree of under-reporting is likely with any voluntary surveillance system. As there was no alternative source available for case ascertainment we cannot estimate the potential extent of underreporting. However, with monthly reminders we expect it to be relatively low. In some cases, pathology other than VDD may have contributed to the development of hypocalcaemia, such as immaturity of the parathyroid axis and hypomagnesaemia in neonates. Three children (4.2%) had low PTH levels suggesting coexisting hypo-parathyroidism; two moderately premature neonates (32-36 weeks gestation) aged Ͻ 1 week (one Pakistani, one Caucasian), and a 5-month-old Pakistani with radiological signs of rickets and a raised ALP, and all were vitamin D deficient (10 -15.9 nmol/L).
The current implementation of public health policy in the UK is not preventing children from developing severe manifestations of VDD. The Department of Health advises that all pregnant women, and all children aged 6 months to 5 years consuming Ͻ 500 ml/d of infant formula milk, take a daily vitamin D supplement of between 300 -400 U. However, supplements are only available free of charge to low-income families through the Healthy Start Scheme, and uptake is low (19) . The Chief Medical Officer has instructed the National Institute for Health and Care Excellence to examine the cost-effectiveness of universal supplement provision (20) . Robust data regarding the epidemiology and health burden of VDD is necessary to guide public health decisions. Given that 27% of cases were Ͻ 1 month of age, our results support recommendations to promote supplementation during pregnancy and in infants from soon after birth, at least in at-risk ethnic groups (7) . Nineteen percent of cases were exclusively formula-fed, questioning whether current guidance that formula-fed infants do not require additional supplementation is appropriate. Further studies are required to evaluate the epidemiology of symptomatic VDD more broadly in the UK. 
